Clinical Trial Update: Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating timolol nasal spray for epistaxis in hereditary hemorrhagic telangiectasia has completed, reporting on its efficacy in reducing noseb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemorrhagic Telangiectasia

Drugs mentioned

• Timolol nasal spray (timolol)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Telangiectasia, Hereditary Hemorrhagic, Osler Rendu Disease | Phase 2 | Status: COMPLETED